Deciphering Somogyi: How Continuous Data Unmasks Rebound Hyperglycemia in Dogs and Cats

You can prove a true Somogyi rebound in diabetic dogs and cats when CGM shows insulin driving glucose below a safe nadir, then a steep, sustained post‑nadir surge that overshoots baseline and makes the day look “high all day.” Quantify time below range, nadir depth, peak–nadir delta, and rate of rise, and confirm that the rebound occurs within 2–8 hours after food or missed doses. Repeat the pattern across days to strengthen causality—next you’ll see how to act on it safely.

What Is the Somogyi Effect in Dogs and Cats?

Why can a dog or cat look “insulin-resistant” on paper while actually getting too much insulin? You see the Somogyi effect when insulin drives glucose levels below the patient’s safe range, and counterregulatory hormones (glucagon, epinephrine, cortisol, growth hormone) then trigger hepatic glycogenolysis and gluconeogenesis. Hours later, spot checks capture only the rebound hyperglycemia, so the curve appears “high all day,” and dose escalation feels logical. That’s the core of Somogyi misconceptions: you’re treating the rebound, not the nadir. With modern CGM interpretation, you can quantify time below range, nadir depth, and rebound timing, linking hypoglycemic exposure to subsequent hyperglycemia and variability. You’ll often see a sharp drop, a brief low, then a prolonged overshoot.

Is It Somogyi, or Just Not Enough Insulin?

When your CGM trace (or a well-timed curve) looks “high all day,” how do you tell the difference between true underdosing and Somogyi rebound? You don’t guess—you structure the data question, then adjust with disciplined insulin titration. To cut Somogyi confusion, prioritize context over single numbers and confirm that “high” reflects biology, not process noise. Use this checklist:

1. Verify dose delivery: correct syringe, U-40/U-100 match, injection technique, site rotation.

2. Validate monitoring: CGM calibration rules, sensor lag, and confirm outliers with a spot BG.

3. Audit confounders: infection, pancreatitis, hyperadrenocorticism, diet shifts, steroids.

4. Quantify exposure: time in range, mean glucose, variability, and postprandial excursions.

If these are clean and hyperglycemia persists, you’re likely underdosed and can escalate safely.

What Somogyi Looks Like on a CGM Trace

On a CGM trace, you’ll suspect Somogyi when you see a clear post-nadir glucose surge after a documented low, often rising rapidly into sustained hyperglycemia. You’ll often catch an overnight rebound pattern—low or rapidly falling glucose followed by early-morning highs—that repeats day after day despite similar feeding and dosing. You’ll also see an insulin timing mismatch, in which the nadir occurs earlier or deeper than intended, and the subsequent hyperglycemia is attributable to counterregulatory recovery rather than simple underdosing.

Post-Nadir Glucose Surge

How do you spot Somogyi on a CGM trace without guessing? You look for a quantifiable post-nadir glucose surge that follows a documented low, rather than a vague “high later” pattern—this corrects common Somogyi misconceptions. On CGM, the signal is temporal: glucose drops to a nadir, then rebounds sharply within hours, often exceeding the pre-nadir baseline.

1. Confirm nadir timing and depth (trend arrow + absolute value).

2. Measure rebound amplitude: peak–nadir delta and rate of rise (mg/dL/hr).

3. Check concordance with insulin action window and feeding timestamps.

4. Validate with repeat days: same sequence, similar kinetics, fewer artifacts.

If you quantify these steps, you’ll separate rebound physiology from sensor noise and routine variability.

Overnight Rebound Pattern

Although daytime variability can obscure patterns, the overnight Somogyi signature on a CGM trace tends to look unusually “clean”: a clear nocturnal nadir (often during the expected peak insulin action window) followed by a steep, sustained rise that overshoots the pre-nadir baseline and persists into the early morning despite no food intake. You’ll often see the nadir drop below your safety threshold, then a rebound climb of ≥100–200 mg/dL over 2–4 hours with minimal oscillation. In dogs and cats, this pattern repeats across multiple nights, strengthening causality beyond single-point curves. Use time-stamped CGM data to align the nadir with indie sleep and confirm no snack, vomiting, or sensor artifact. When you quantify overnight patterns—nadir depth, rebound slope, and duration—you can distinguish true rebound hyperglycemia from random noise.

Insulin Timing Mismatch

Why does “rebound” show up right after a dose change, even when the nadir isn’t dramatically low? You often see insulin timing mismatches: the dose lands when glucose is already dropping, then the action peaks during reduced intake or sleep, triggering counterregulation. On CGM, that looks like a steep post-dose descent followed by a sharp, sustained rise that overshoots baseline, with high variability rather than a single extreme low.

Use CGM interpretation to test timing, not just units:

1. Compare dose time to meal and activity timestamps.

2. Measure slope (mg/dL/min) into nadir; rapid falls predict rebound.

3. Track time-below-range and subsequent hyperglycemia amplitude.

4. Re-run after shifting dosing/feeding by 30–60 minutes.

Why Glucose Curves Often Miss Somogyi Lows

In everyday practice, where do Somogyi-triggering lows actually hide on a standard glucose curve? They often occur between sampling points, during sleep, post-exercise, or after a delayed meal, so your 2–3-hour checks can miss a 20–60-minute nadir. Stress hyperglycemia and clinic handling can also elevate measured values, masking preceding hypoglycemia and setting up Somogyi misinterpretation.

You’re also constrained by curve design: limited duration, fewer points near the expected nadir, and day-to-day variability in insulin absorption. A single “flat high” curve can reflect rebound after an unobserved dip rather than underdosing. Even when you add spot checks, meter imprecision at low ranges, and capillary sampling differences can blur true nadirs. Ironically, CGM data gaps due to sensor compression or signal loss can appear safe while masking brief hypoglycemia.

How to Confirm Somogyi With CGM (Step-by-Step)

To confirm Somogyi with CGM, you first identify a true hypoglycemia nadir by pinpointing the lowest interstitial glucose and its duration relative to the insulin dose. Next, you document rebound hyperglycemia by showing a sustained post-nadir rise into high ranges that persists beyond expected postprandial variation. When you capture this low-then-high sequence on the same dosing cycle, you’ve got objective, time-linked evidence consistent with rebound.

Identify Hypoglycemia Nadir

When, exactly, does a Somogyi pattern begin on CGM? It starts at the hypoglycemia nadir, so your CGM interpretation must first lock onto the lowest glucose point, not the later trajectory. Use the raw trace and timestamps to define a defensible nadir, then validate it with context and sensor performance.

Confirm data integrity: check wear-time, signal gaps, compression artifacts, and calibration notes. Locate the minimum value within the insulin action window; record mg/dL and clock time. Quantify depth and duration: compute minutes below your clinic’s hypoglycemia threshold and area-under-threshold. Corroborate biologic plausibility: align nadir timing with dose, meal, exercise, and concurrent meds; consider a spot blood glucose if values are borderline.

A true nadir is reproducible across adjacent days, even if its timing shifts.

Document Rebound Hyperglycemia

A defensible Somogyi call requires that you document rebound hyperglycemia as a time-locked physiologic response to the nadir, not as a generic high later in the day. On CGM, mark the nadir time and value, then define a rebound window (typically 2–8 hours post-nadir) and quantify the rise. Confirm that glucose climbs rapidly (e.g., ≥100 mg/dL) to sustained hyperglycemia (often >250–300 mg/dL) without intervening food, stress, or missed insulin. Verify that the rebound peak consistently follows low nadirs across at least two comparable days and aligns with the same dose and timing. Use rate-of-change and area-above-range metrics to objectify the pattern. This workflow reduces Somogyi misinterpretation and rebound confusion when adjusting insulin safely.

How to Fix Somogyi: Prevent the Low, Stop the Rebound

How do you fix Somogyi rebound in dogs and cats? You prevent biochemical hypoglycemia, then verify improvement with continuous trends, not spot checks. Start by ruling out Somogyi misinterpretation from CGM misreadings (compression lows, sensor lag, calibration error) by confirming nadirs with a blood glucose meter when values are discordant. Then act on the data:

1. Reduce insulin dose 10–25% if nadir <70 mg/dL (dogs) or <80 mg/dL (cats).
2. Adjust timing/food: split meals, add a pre-nadir snack, and avoid delayed feeding.
3. Reassess insulin type/duration; switch to a flatter profile if steep drops persist.
4. Re-run CGM 10–14 days, target 70–250 mg/dL with minimal time <70.

You’ll stop counterregulatory surges and stabilize curves.

Frequently Asked Questions

1. How Common Is Somogyi Rebound in Diabetic Dogs Versus Cats?

Somogyi rebound appears uncommon in both species; you’ll encounter it more in dogs than in cats, but rigorous studies show a low prevalence overall. You should suspect it only when documented hypoglycemia precedes hyperglycemia, confirming the Rebound mechanism (counter‑regulatory hormones driving glucose overshoot). In cats, apparent “Somogyi” often reflects stress hyperglycemia or remission dynamics. You’ll get the best incidence estimate using CGM rather than curves.

2. Can Steroids or Other Medications Mimic Somogyi on CGM?

Yes—steroids and other meds can mimic Somogyi on CGM. Think of one dog whose prednisone “turned up the thermostat”: CGM showed persistent highs, then a sharp dip after an increase in insulin, followed by rebound spikes. That’s steroid mimicry plus possible med-induced hypoglycemia if insulin overshoots. You’ll confirm by timing: hyperglycemia tracks dosing, lows follow insulin peaks, and ketones stay negative; adjust insulin and review meds.

3. What CGM Brands Are Most Reliable for Detecting Hypoglycemia in Pets?

You’ll get the most reliable pet hypoglycemia detection from Abbott FreeStyle Libre (Libre 2/3) and Dexcom G6/G7, used off‑label with veterinary validation. Libre offers strong field performance, wide availability, and good Diabetes management workflows; Dexcom adds real‑time alerts that tighten response times. For CGM interpretation, you’ll still confirm low readings with a blood glucose meter, especially during rapid drops, compression lows, or poor sensor adhesion.

4. Does Diet Timing or Composition Affect the Likelihood of Somogyi Rebound?

Yes—diet timing and diet composition can change Somogyi risk by shifting post‑meal glucose curves relative to insulin action. If you feed late, skip meals, or vary carbohydrate load, you increase the chance of insulin‑meal mismatch and nadir hypoglycemia, which can trigger counterregulatory hyperglycemia. Use consistent meal timing with dosing, favor lower‑glycemic, higher‑fiber/protein profiles, and avoid high‑simple‑carb treats; validate with CGM nadir and AUC trends.

5. When Should My Pet Be Hospitalized for Suspected Severe Hypoglycemia?

Head to an emergency hospital now—don’t wait—for seizures, collapse, profound lethargy, tremors, vomiting, or if your pet can’t safely swallow. Treat this like a telegraph alarm: minutes matter. If home glucose reads <60 mg/dL or CGM shows rapid drops, you need IV dextrose, monitoring, and dose review. Verify CGM calibration to avoid Somogyi false positives, but never delay care while rechecking. Bring insulin, food, and logs.

Conclusion

Somogyi rebound can lead you to increase insulin when your patient actually needs less. With CGM, you’ll see the signature: a nadir below target followed by counterregulatory hyperglycemia. That pattern rarely shows on single curves, which can miss brief, nocturnal lows. Treat CGM like a flight recorder: it captures the drop that triggers the surge. Confirm timing, dose, and meals, then reduce insulin or adjust feeding to prevent the low and stabilize glycemia.